Rahman Mobeen, Okada Ashley Rae, Guan Kevin, Tauchi-Nishi Pamela
Address: Department of Pathology, University of Hawaii, Honolulu, Hawaii, USA.
Department of Pathology, The Queens Medical Center, Honolulu, Hawaii, USA.
Cytojournal. 2017 Jun 20;14:16. doi: 10.4103/cytojournal.cytojournal_50_16. eCollection 2017.
Although thyroid fine-needle aspiration (FNA) and core needle biopsy (CNB) are commonly utilized modalities in the evaluation of thyroid nodules, metastatic tumors to the thyroid are only rarely encountered. We aspired to determine the incidence and primary origin of metastases to the thyroid at our institution and to examine their clinicopathologic and cytomorphologic features.
A search of our database was undertaken to review all thyroid FNA and/or CNB examined between January 2004 and December 2013.
During our 10 year study period, 7497 patients underwent 13,182 FNA and/or CNB. Four hundred sixty one (6%) patients were diagnosed with neoplasms. Only five (1.1%) were found to have metastatic tumors to the thyroid involving three females and two males. Two were diagnosed by FNA, one by CNB, and two by both FNA and CNB, with rapid on-site evaluation (ROSE) employed in all cases. The primary malignancies in the five cases were pulmonary and nasopharyngeal squamous cell carcinomas, renal cell carcinoma, pancreatic adenocarcinoma, and olfactory neuroblastoma. The cytomorphologic features of these metastases to the thyroid aided in their distinction from primary thyroid carcinoma. Two of these metastases, a renal cell carcinoma and pancreatic adenocarcinoma, were the first clinical manifestations of cancer.
Metastases to the thyroid diagnosed by FNA and/or CNB are exceedingly rare in our institution, comprising only 0.04% of total FNA/CNB and only 1.1% of all thyroid neoplasms. We report the first known case of metastatic olfactory neuroblastoma to the thyroid diagnosed by aspiration cytology. In addition, an occult primary may present as a thyroid mass on FNA or CNB as occurred with two of our cases. FNA/CNB proved to be highly effective in the diagnosis of metastases to the thyroid, with ROSE proving valuable in assuring specimen adequacy. Thyroid FNA and CNB demonstrated great utility in the setting of metastatic disease, obviating the need for more invasive procedures.
尽管甲状腺细针穿刺抽吸活检(FNA)和粗针活检(CNB)是评估甲状腺结节常用的方法,但甲状腺转移瘤却很少见。我们旨在确定我院甲状腺转移瘤的发生率和原发部位,并研究其临床病理和细胞形态学特征。
检索我院数据库,回顾2004年1月至2013年12月期间所有接受甲状腺FNA和/或CNB检查的病例。
在我们为期10年的研究期间,7497例患者接受了13182次FNA和/或CNB检查。461例(6%)患者被诊断为肿瘤。仅5例(1.1%)发现有甲状腺转移瘤,其中3例女性,2例男性。2例通过FNA诊断,1例通过CNB诊断,2例通过FNA和CNB联合诊断,所有病例均采用快速现场评估(ROSE)。5例病例的原发恶性肿瘤分别为肺和鼻咽鳞状细胞癌、肾细胞癌、胰腺腺癌和嗅神经母细胞瘤。这些甲状腺转移瘤的细胞形态学特征有助于将其与原发性甲状腺癌区分开来。其中2例转移瘤,即肾细胞癌和胰腺腺癌,是癌症的首发临床表现。
在我院,通过FNA和/或CNB诊断的甲状腺转移瘤极为罕见,仅占FNA/CNB总数的0.04%,占所有甲状腺肿瘤的1.1%。我们报告了首例通过细针穿刺细胞学诊断的甲状腺转移嗅神经母细胞瘤。此外,隐匿性原发肿瘤可能表现为FNA或CNB检查时的甲状腺肿块,我们的2例病例即如此。FNA/CNB被证明在诊断甲状腺转移瘤方面非常有效,ROSE在确保标本充足方面很有价值。甲状腺FNA和CNB在转移性疾病中显示出巨大的实用性,无需进行更具侵入性的检查。